Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
As of today, Johnson & Johnson(JNJ) shares are valued at $219.00. The company's market cap stands at 536.52B, with a P/E ratio of 20.62 and a dividend yield of 2.4%.
On 2026-01-14, Johnson & Johnson(JNJ) stock traded between a low of $213.13 and a high of $219.00. Shares are currently priced at $219.00, which is +2.8% above the low and 0.0% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 11.86M, against a daily average of 7.54M.
During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $219.00 at its peak.
During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $219.00 at its peak.
JNJ News
Johnson & Johnson announced positive topline results from the investigational Phase 3 MajesTEC-9 study of tecvayli – teclistamab-cqyv – monotherapy, showing a 7...
If you are wondering whether Johnson & Johnson is still reasonably priced after its recent run, this article will walk through what the current share price migh...
Claim 70% Off TipRanks Premium An announcement from Clarity Medical Group Holding Limited ( (HK:1406) ) is now available. Clarity Medical Group Holding Limite...
Analyst ratings
56%
of 27 ratingsMore JNJ News
Johnson & Johnson (NYSE:JNJ) on Monday reportedly secured a partial legal victory after Delaware's highest court overturned a portion of a $1 billion damages aw...
Johnson & Johnson's JNJ medical devices segment, known as MedTech, offers products in the orthopedics, surgery, cardiovascular and vision markets. The MedTech s...
On Saturday, Johnson & Johnson (NYSE:JNJ) shared new longer follow-up results from the Phase 1b/2 OrigAMI-1 study. The trial is evaluating Rybrevant (amivantam...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Eli Lilly (NYSE:...
Bernstein analyst Lee Hambright raised the firm’s price target on Johnson & Johnson to $208 from $193 and keeps a Market Perform rating on the shares. After a l...
Biotech and Pharma Johnson & Johnson Strikes Deal With White House to Lower Drug Prices In this article JNJ NOVN MRK GSK Johnson & Johnson agrees to lower price...
↘️ General Motors (GM) : The carmaker said it would book a $6 billion charge on its money-losing electric-vehicle business. Shares dropped 1.4% in offhours trad...
